BRISBANE, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Cutera, Inc.(R) , a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today announced two new offerings, Titan(TM) V and Titan XL, designed to complement the current and widely used Titan procedure.
“Building on the success of Titan and in an effort to meet the changing needs of our customers, we have developed two new offerings for faster treatments and improved visibility,” said Kevin Connors, president and CEO of Cutera. “All our Titan customers have the option to upgrade their existing systems. This is yet another example of the upgradeable path offered to our customers.”
The Titan V has a treatment tip that extends beyond the handpiece housing to give an unobstructed view of the skin’s surface. With enhanced visibility, the clinician can better see where the light is in contact with the skin. This makes it easier to treat the delicate eye and nose areas.
The Titan XL not only extends beyond the housing for unimpeded visibility, but also has a treatment spot size that is twice as large as the Titan V’s. With a larger spot size, clinicians can perform procedures twice as fast and treat larger body areas, such as arms, abdomens and legs.
“I’ve seen excellent results with the original Titan,” said Amy Taub, MD, founder and medical director of Advanced Dermatology. “And now these two new offerings are built in such a way that they give me even better visibility for treating sensitive areas, including around the eyes and nose. I can treat my patients even faster which saves time, and therefore, lets me treat more patients.”
About Titan
Titan is the first light-based solution to target the dermis and provide uniform, sustained heating to the deep layers of the skin, while simultaneously protecting the epidermis. Patients feel minimal or no discomfort. Titan is available on both the Xeo and Solera platforms.
About Cutera, Inc.
Brisbane, Calif.-based Cutera is a leading provider of laser and other light-based aesthetic systems to the professional aesthetic market. Since 1998, Cutera has been developing innovative, easy-to-use products that enable dermatologists, plastic surgeons, gynecologists, primary care physicians and other qualified practitioners to offer safe, effective and non-invasive aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning the anticipated success of new product offerings are forward-looking statements within the meaning of the Safe Harbor. Forward- Looking statements are based on management’s current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera’s actual results to differ materially from the statements contained herein. Further information on potential risk factors that could affect Cutera’s business and its financial results are detailed in its most recent 10-K and 10-Q as filed with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
Cutera, Inc.
CONTACT: Elizabeth Conrady of Cutera, Inc., +1-415-657-5503, oreconrady@cutera.com; or Brooke Hilton of Rpr Marketing Communications,+1-212-317-1462, or brooke.hilton@rprny.com, for Cutera
Web site: http://www.cutera.com/
